reports
- GlobalData Healthcare Department
Amicogen Inc (092040) - Financial Analysis Review
Amicogen Inc (092040) - Financial Analysis Review Summary Amicogen Inc (Amicogen) is an industrial biotechnology company that develops, produces and sells enzyme-based health ingredients. The company offers specialty enzymes, immunological products, new bio-ingredients and nutraceuticals. Its products comprise biocatalyst, chitosanase, lipase PF, nuclease SM, collagen peptide, collagen tri-peptide, spore lactic acid bacteria, protein A chromatography resin, and others. Amicogen caters to food,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.